Medical News

RSS

Cause of exercise intolerance in heart failure patients

A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center.

19 Nov 2006

Experimental drug provides powerful therapy against acute myeloid leukemia

Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.

19 Nov 2006

Cigarette smoking and high HPV concentrations associated with greater risk of cervical cancer

Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.

19 Nov 2006

Structured exercise may enhance seniors' physical functioning

A structured exercise program may boost the physical well-being of sedentary seniors who are at risk of losing independent functioning, a new study to be published in the November 2006 Journal of Gerontology: Medical Sciences has found.

19 Nov 2006

Gene expression and lung cancer prognosis

While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.

19 Nov 2006

Evolution is driving therapeutic resistance to cancer therapies

The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.

19 Nov 2006

FDA expands use of Herceptin

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy).

19 Nov 2006

FDA approves silicone gel-filled breast implants

After rigorous scientific review, the U.S. Food and Drug Administration (FDA) has approved the marketing of silicone gel-filled breast implants made by two companies for breast reconstruction in women of all ages and breast augmentation in women ages 22 and older.

19 Nov 2006